Neurohormonal activation pattern in patients with atrial septal defect

Area of Science:

• Cardiology
• Endocrinology
• Physiology

Background:

• Atrial septal defects (ASD) cause abnormal blood flow, necessitating compensatory mechanisms for circulatory volume.
• Neurohormonal activation plays a critical role in managing circulatory dynamics in ASD patients.

Purpose of the Study:

• To investigate the specific patterns of neurohormonal activation in individuals with ASD.
• To understand how these neurohormonal patterns change after surgical closure of the ASD.

Main Methods:

• Compared neurohormonal profiles of 16 ASD patients against 10 healthy controls.
• Collected fasting blood samples at baseline and 48 hours post-ASD closure.
• Measured levels of renin, aldosterone, copeptin, natriuretic peptides, noradrenaline, and endothelin-1.

Main Results:

• ASD patients exhibited elevated baseline levels of renin, aldosterone, copeptin, and natriuretic peptides compared to controls.
• Conversely, noradrenaline and endothelin-1 levels were higher in controls than in ASD patients.
• Post-closure, only NT-proBNP showed a significant reduction (p=0.02).
• Negative correlations were observed between defect size and noradrenaline (r=-0.73, p=0.002) and endothelin-1 (r=-0.59, p=0.02).

Conclusions:

• ASD is associated with increased plasma volume-regulating hormones (aldosterone, arginine vasopressin) and decreased vasoconstrictive hormones (noradrenaline, endothelin-1).
• ASD closure leads to a significant reduction in NT-proBNP, suggesting a normalization of cardiac strain.
• These findings highlight the complex neurohormonal adaptations in ASD and their response to corrective surgery.